Riskpilot← Back to searchSign inGet full accessA.M.I. NORDIC AS
ASActiveOrg 916499175Drammensveien 288, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20160 employees
Revenue 2022
NOK 3,4M
-50% vs 2021
EBITDA margin
-40.2%
-94% vs 2021
Equity ratio
85.4%
Financial strength
Net profit 2022
NOK -1,5M
-188% vs 2021
| Revenue | NOK 3,4M | -50% |
| EBITDA | NOK -1,4M | -94% |
| Net profit | NOK -1,5M | -188% |
| Total assets | NOK 687K | -75% |
| Equity | NOK 587K | -72% |
| Employees | 0 | — |
Legal name
A.M.I. NORDIC AS
Org number
916499175
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4. januar 2016
Share capital
NOK 200 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Tilby medisinsk utstyr til private- og offentlige sykehus, herunder handel, import/eksport samt samarbeid eller deltagelse i andre selskap med lignende virksomhet.
Address
Drammensveien 288, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 8 797 | 7 855 | 8 368 | 6 663 | 3 361 |
| Staff expenses | −2 823 | −2 670 | −1 685 | −0 | −947 |
| EBITDA | 848 | 195 | 953 | −695 | −1 351 |
| Depreciation & amort. | −22 | −54 | −57 | −5 | −9 |
| EBIT | 826 | 141 | 896 | −700 | −1 360 |
| Net financials | −100 | −82 | −105 | 16 | −10 |
| Profit before tax | 726 | 60 | 791 | −685 | −1 370 |
| Tax | 59 | 30 | 176 | −0 | 173 |
| Net profit | 667 | 29 | 615 | −536 | −1 543 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 4 284 | 3 777 | 4 753 | 2 777 | 687 |
| Equity | 2 023 | 2 052 | 2 667 | 2 130 | 587 |
| Long-term debt | 4 | 4 | 0 | 0 | 0 |
| Short-term debt | 2 257 | 1 720 | 2 087 | 647 | 100 |
| Total debt | 2 261 | 1 724 | 2 087 | 647 | 100 |
EBITDA margin
-40.2%
This company
15.8%
Market median
-354% vs market
20182022
Equity ratio
85.4%
This company
38.2%
Market median
+124% vs market
20182022
Return on equity
-263.0%
This company
18.4%
Market median
-1529% vs market
20182022
Net profit margin
-45.9%
This company
8.1%
Market median
-667% vs market
20182022
Asset turnover
4.89×
This company
1.12×
Market median
+337% vs market
20182022
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Chairman | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Chairman | 2017 – 2021 | |
| Board of Directors | 2017 – 2021 | |
| Chairman | 2021 – 2022 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Patro As
A.M.I. NORDIC AS Board members of A.M.I. NORDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marc Günter Jablonowski | Chairman | 0 companies |
| Christoph Walter | Deputy Chairman | 0 companies |
| Anton Josef Bentele | Board of Directors | 0 companies |
| Jonas Thomas Schnider | Chairman | 0 companies |
| Ralf Markstahler | Chairman | 0 companies |
| Thomas Elton | Board of Directors | 0 companies |